# China NMPA Drug Inspection - Zhejiang Cheng Yi Pharmaceutical Co., Ltd. - Ribavirin Injection

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/zhejiang-cheng-yi-pharmaceutical-co-ltd/15f65980-e254-4148-956e-d85c7d35fa9a
Source feed: China

> China NMPA drug inspection for Zhejiang Cheng Yi Pharmaceutical Co., Ltd. published October 29, 2021. Drug: Ribavirin Injection. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: The Yunnan Provincial Drug Administration issued the third issue of its 2021 Drug Quality Bulletin.
- Company Name: Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
- Publication Date: 2021-10-29
- Drug Name: Ribavirin Injection
- Inspection Finding: Compliant

Company: https://www.globalkeysolutions.net/companies/zhejiang-cheng-yi-pharmaceutical-co-ltd/dabc68a0-9969-418a-9cd6-54e9987ed8df